Longevity News

Engineering Probiotic Consortia to Improve Chemotherapy Tolerance and Reduce Toxicity in Breast Cancer Patients: A New Frontier in Supportive Precision Oncology

Source: Frontiers - Health • Published: 14 Aug 2026, 00:00

Engineering Probiotic Consortia to Improve Chemotherapy Tolerance and Reduce Toxicity in Breast Cancer Patients: A New Frontier in Supportive Precision Oncology

Survey of engineered multi-strain probiotic consortia as supportive interventions to reduce chemotherapy toxicity and preserve gut health in breast cancer care.

Key Takeaways
  • You have multiple emails registered with Frontiers: You don't have a Frontiers account ?
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
  • Distribution or reproduction in other forums is permitted
Read Original Source